Madrigal Pharmaceuticals
Biopharmaceutical company specializing in metabolic dysfunction-associated steatohepatitis (MASH) treatments, developer of resmetirom (Rezdiffra) for chronic liver disease and cardiovascular risk reduction
About
What Madrigal Pharmaceuticals is
Biopharmaceutical company specializing in metabolic dysfunction-associated steatohepatitis (MASH) treatments, developer of resmetirom (Rezdiffra) for chronic liver disease and cardiovascular risk reduction
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://madrigalpharmaceuticals.com |
| Status coverage | Public status page |
| Founded | 2011 |
| Headquarters | West Conshohocken, Pennsylvania, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...